3D Analysis of the Effects of tDCS (Transcranial Direct Current Stimulation) on a Functional Task in High Level Athletes
NCT ID: NCT03901222
Last Updated: 2020-03-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10 participants
INTERVENTIONAL
2019-03-31
2019-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
tDCS to Increase Aerobic Performance in Runners
NCT04005846
Neurophysiological Study of tDCS Effects in Healthy Volunteers
NCT02125422
Effect of Repeated tDCS Sessions on Cognitive Improvement in Patients With Disorders of Consciousness
NCT02394691
Multichannel tDCS to Reduce Hypertonia in Patients With Prolonged DOC
NCT03797573
EEG Analytics to Determine Effectiveness of a tDCS Protocol
NCT03537885
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Relatively high level athletes will be recruited through social media and advertisements.
Each subject came twice to the Liege University Hospitals' Human Movement Analysis Laboratory.
After placing the different infrared emitters and placing and calibrating the surface EMG electrodes, subjects underwent 3 maximal squat jumps (without upper limb implication). They were then familiarized with the fatigue protocol (8 jumps at a 33 jumps per minute pace).
Then each subject received either bi-anodal tDCS of sham tDCS. Neither the evaluator or the subject knew which they were receiving. Immediately following tDCS, subjects underwent another warmup 3 maximal squat jumps, and then the fatigue protocol (comprised of 30 maximal jumps at a rate of 33 per minute).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
HEALTH_SERVICES_RESEARCH
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bi-Anodal tDCS
Subjects will receive 20 min of bi-anodal tDCS
tDCS
20 minutes of anodal tDCS (C3 \& C4/FPZ) 2mA or sham
Sham tDCS
Subjects will receive 20 minutes of Sham anodal tDCS
tDCS
20 minutes of anodal tDCS (C3 \& C4/FPZ) 2mA or sham
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
tDCS
20 minutes of anodal tDCS (C3 \& C4/FPZ) 2mA or sham
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Right handed and footed
Exclusion Criteria
* Previous neurological or orthopedic pathologies affecting limbs
18 Years
35 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Liege
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bornheim Stephen
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stephen Bornheim, Msc
Role: PRINCIPAL_INVESTIGATOR
Liege University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Liege Univeristy Hospital
Liège, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017/309
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.